Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
?

?

2.090%
0.08
2.090%
€17.31
 
07:31 / Stuttgart Stock Exchange WKN: A2JQN1 / Symbol: REPL / Name: Replimune Group / Stock / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.

Replimune Group Inc Stock

There is an upward development for Replimune Group Inc compared to yesterday, with an increase of €0.080 (2.090%).
With 14 Buy predictions and only 2 Sell predictions the community sentiment for the stock is positive.
Based on the current price of 3.9 € the target price of 17 € shows a potential of 335.9% for Replimune Group Inc which would more than double the current price.
For the coming years our community has positive and negative things to say abot the Replimune Group Inc stock. Criterium "Worthwhile Investment for the next years" gathered the most positive votes but regarding "Unique positioning" there were negative voices in the community.

Pros and Cons of Replimune Group Inc in the next few years

Pros
?
W********* I********* f** t** n*** y****
?
B****
?
M***** P*******
Cons
?
S********** s********
?
G***** c******* t* c**********
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'

sharewise BeanCounterBot

The analysis provided is generated by an artificial intelligence system and is provided for informational purposes only. We do not guarantee the accuracy, completeness, or usefulness of the analysis, and we are not responsible for any errors or omissions. Use of the analysis is at your own risk.
Last updated at 2023-10-30

Eine erste Durchsicht der Finanzunterlagen der Replimune Group zeigt ein gemischtes Bild. Während einige Aspekte positiv aufgenommen werden können, deuten andere auf mögliche Herausforderungen hin, die das Unternehmen in Zukunft bewältigen muss.

Beginnen wir mit den Vorteilen in der Finanzsituation der Replimune Group. Das Unternehmen verfügt über ein beachtliches Kapital von 555 Millionen US-Dollar (Stand 2023), was bedeutet, dass es über ausreichende Ressourcen verfügt, um seine aktuellen Geschäftsaktivitäten zu unterstützen. Außerdem ist erfreulich, dass die Aktien des Unternehmens relativ stabil geblieben sind, mit einer geringen Änderung im Jahr, was auf eine stabile Anlegerbasis hindeutet.

Darüber hinaus verfügt die Replimune Group über eine erhebliche Menge an kurzfristigen Investitionen (436 Millionen US-Dollar) im Jahr 2023. Diese können in bar umgewandelt werden, falls das Unternehmen Liquidität benötigt, was seine finanzielle Flexibilität erheblich verbessert.

Comments

Replimune Group (NASDAQ:REPL) had its "underweight" rating reaffirmed by analysts at JPMorgan Chase & Co..
Ratings data for REPL provided by MarketBeat
Show more

Replimune Group, Inc. (NASDAQ: REPL) was upgraded by analysts at Cantor Fitzgerald from a "neutral" rating to an "overweight" rating.
Ratings data for REPL provided by MarketBeat
Show more

Prediction Sell
Perf. (%) 67.50%
Target price 1.704
Change
Ends at 23.07.26

Replimune Group, Inc. (NASDAQ: REPL) was downgraded by analysts at BMO Capital Markets from an "outperform" rating to an "underperform" rating. They now have a $2.00 price target on the stock.
Ratings data for REPL provided by MarketBeat
Show more

News

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune
FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Replimune


Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Replimune Group, Inc. (“Replimune” or the “Company”) (NASDAQ: REPL) and reminds investors of